Randomised controlled clinical effectiveness trial of cognitive behaviour therapy (CBT) versus treatment as usual (TAU) for insomnia in cancer patients

CA Espie, L Fleming

Research output: Contribution to journalConference Contribution

Abstract

Introduction : Epidemiologic studies have shown that insomnia is particularly common amongst cancer patients, with many continuing to report sleeping difficulties one year after completion of cancer treatment. Conventional wisdom on the natural history of insomnia has recently been applied in the context of cancer, suggesting the appropriateness of a biopsychosocial treatment model. There is emerging evidence that intervening at the psychosocial level using cognitive behavioural therapies (CBT) can be effective for insomnia associated with cancer. We aim therefore to assess the benefits of CBT for insomnia in a cancer population. Methods : 150 individuals from four cancer groups (breast, prostate, colorectal and gynaecological) participated in the study. All had completed anti-cancer treatment and satisfied the diagnostic criteria for chronic insomnia. The mean age of the sample was 61 years and the mean duration of their insomnia was 53 months. A 2:1 randomisation process in favour of the intervention (100 in CBT and 50 in TAU) was in operation. Results : For the CBT group, baseline (BL) and post treatment (PT) comparisons yielded statistically significant differences (p<0.05) on all subjectively assessed sleep variables [sleep onset latency (SOL), wake time after sleep onset (WASO), total sleep time (TST), time in bed (TIB) and sleep efficiency (SE)]. SOL reduced from 49mins at BL to 21mins at PT; WASO reduced from 80mins (BL) to 38mins (PT); TST increased from 389mins (BL) to 416mins (PT); TIB reduced from 517mins (BL) to 475mins (PT) and SE increased from 75% (BL) to 87% (PT). Analyses on measures of psychopathology and fatigue also generated significant results for the CBT group. Comparisons on the same variables within the TAU group produced no significant differences. Conclusion : These findings demonstrate the effectiveness of using CBT to treat severe and persistent insomnia in cancer populations. This effectiveness does not diminish due to the existence of physical symptoms such as pain or treatment side effects.
LanguageEnglish
Article number0753
PagesA256
Number of pages1
JournalSLEEP
Volume29
Issue numberSupp.
Publication statusPublished - 2006
EventSLEEP 2006, 20th Anniversary Meeting of the Associated Professional Sleep Socieities - Salt Lake City, United States
Duration: 17 Jun 200622 Jun 2017

Fingerprint

Sleep Initiation and Maintenance Disorders
Cognitive Therapy
Randomized Controlled Trials
Sleep
Neoplasms
Therapeutics
Random Allocation
Psychopathology
Population
Fatigue
Epidemiologic Studies
Prostate
Breast Neoplasms

Cite this

@article{08ef860045e347a38a8675fb0e4a56cd,
title = "Randomised controlled clinical effectiveness trial of cognitive behaviour therapy (CBT) versus treatment as usual (TAU) for insomnia in cancer patients",
abstract = "Introduction : Epidemiologic studies have shown that insomnia is particularly common amongst cancer patients, with many continuing to report sleeping difficulties one year after completion of cancer treatment. Conventional wisdom on the natural history of insomnia has recently been applied in the context of cancer, suggesting the appropriateness of a biopsychosocial treatment model. There is emerging evidence that intervening at the psychosocial level using cognitive behavioural therapies (CBT) can be effective for insomnia associated with cancer. We aim therefore to assess the benefits of CBT for insomnia in a cancer population. Methods : 150 individuals from four cancer groups (breast, prostate, colorectal and gynaecological) participated in the study. All had completed anti-cancer treatment and satisfied the diagnostic criteria for chronic insomnia. The mean age of the sample was 61 years and the mean duration of their insomnia was 53 months. A 2:1 randomisation process in favour of the intervention (100 in CBT and 50 in TAU) was in operation. Results : For the CBT group, baseline (BL) and post treatment (PT) comparisons yielded statistically significant differences (p<0.05) on all subjectively assessed sleep variables [sleep onset latency (SOL), wake time after sleep onset (WASO), total sleep time (TST), time in bed (TIB) and sleep efficiency (SE)]. SOL reduced from 49mins at BL to 21mins at PT; WASO reduced from 80mins (BL) to 38mins (PT); TST increased from 389mins (BL) to 416mins (PT); TIB reduced from 517mins (BL) to 475mins (PT) and SE increased from 75{\%} (BL) to 87{\%} (PT). Analyses on measures of psychopathology and fatigue also generated significant results for the CBT group. Comparisons on the same variables within the TAU group produced no significant differences. Conclusion : These findings demonstrate the effectiveness of using CBT to treat severe and persistent insomnia in cancer populations. This effectiveness does not diminish due to the existence of physical symptoms such as pain or treatment side effects.",
author = "CA Espie and L Fleming",
year = "2006",
language = "English",
volume = "29",
pages = "A256",
journal = "SLEEP",
issn = "0161-8105",
number = "Supp.",

}

Randomised controlled clinical effectiveness trial of cognitive behaviour therapy (CBT) versus treatment as usual (TAU) for insomnia in cancer patients. / Espie, CA; Fleming, L.

In: SLEEP, Vol. 29, No. Supp., 0753, 2006, p. A256.

Research output: Contribution to journalConference Contribution

TY - JOUR

T1 - Randomised controlled clinical effectiveness trial of cognitive behaviour therapy (CBT) versus treatment as usual (TAU) for insomnia in cancer patients

AU - Espie, CA

AU - Fleming, L

PY - 2006

Y1 - 2006

N2 - Introduction : Epidemiologic studies have shown that insomnia is particularly common amongst cancer patients, with many continuing to report sleeping difficulties one year after completion of cancer treatment. Conventional wisdom on the natural history of insomnia has recently been applied in the context of cancer, suggesting the appropriateness of a biopsychosocial treatment model. There is emerging evidence that intervening at the psychosocial level using cognitive behavioural therapies (CBT) can be effective for insomnia associated with cancer. We aim therefore to assess the benefits of CBT for insomnia in a cancer population. Methods : 150 individuals from four cancer groups (breast, prostate, colorectal and gynaecological) participated in the study. All had completed anti-cancer treatment and satisfied the diagnostic criteria for chronic insomnia. The mean age of the sample was 61 years and the mean duration of their insomnia was 53 months. A 2:1 randomisation process in favour of the intervention (100 in CBT and 50 in TAU) was in operation. Results : For the CBT group, baseline (BL) and post treatment (PT) comparisons yielded statistically significant differences (p<0.05) on all subjectively assessed sleep variables [sleep onset latency (SOL), wake time after sleep onset (WASO), total sleep time (TST), time in bed (TIB) and sleep efficiency (SE)]. SOL reduced from 49mins at BL to 21mins at PT; WASO reduced from 80mins (BL) to 38mins (PT); TST increased from 389mins (BL) to 416mins (PT); TIB reduced from 517mins (BL) to 475mins (PT) and SE increased from 75% (BL) to 87% (PT). Analyses on measures of psychopathology and fatigue also generated significant results for the CBT group. Comparisons on the same variables within the TAU group produced no significant differences. Conclusion : These findings demonstrate the effectiveness of using CBT to treat severe and persistent insomnia in cancer populations. This effectiveness does not diminish due to the existence of physical symptoms such as pain or treatment side effects.

AB - Introduction : Epidemiologic studies have shown that insomnia is particularly common amongst cancer patients, with many continuing to report sleeping difficulties one year after completion of cancer treatment. Conventional wisdom on the natural history of insomnia has recently been applied in the context of cancer, suggesting the appropriateness of a biopsychosocial treatment model. There is emerging evidence that intervening at the psychosocial level using cognitive behavioural therapies (CBT) can be effective for insomnia associated with cancer. We aim therefore to assess the benefits of CBT for insomnia in a cancer population. Methods : 150 individuals from four cancer groups (breast, prostate, colorectal and gynaecological) participated in the study. All had completed anti-cancer treatment and satisfied the diagnostic criteria for chronic insomnia. The mean age of the sample was 61 years and the mean duration of their insomnia was 53 months. A 2:1 randomisation process in favour of the intervention (100 in CBT and 50 in TAU) was in operation. Results : For the CBT group, baseline (BL) and post treatment (PT) comparisons yielded statistically significant differences (p<0.05) on all subjectively assessed sleep variables [sleep onset latency (SOL), wake time after sleep onset (WASO), total sleep time (TST), time in bed (TIB) and sleep efficiency (SE)]. SOL reduced from 49mins at BL to 21mins at PT; WASO reduced from 80mins (BL) to 38mins (PT); TST increased from 389mins (BL) to 416mins (PT); TIB reduced from 517mins (BL) to 475mins (PT) and SE increased from 75% (BL) to 87% (PT). Analyses on measures of psychopathology and fatigue also generated significant results for the CBT group. Comparisons on the same variables within the TAU group produced no significant differences. Conclusion : These findings demonstrate the effectiveness of using CBT to treat severe and persistent insomnia in cancer populations. This effectiveness does not diminish due to the existence of physical symptoms such as pain or treatment side effects.

M3 - Conference Contribution

VL - 29

SP - A256

JO - SLEEP

T2 - SLEEP

JF - SLEEP

SN - 0161-8105

IS - Supp.

M1 - 0753

ER -